600513 聯環藥業
按盤價 
17.700 +0.060 (+0.340%) | 2025/09 - 九個月 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | -2.568 | 6.121 | 10.303 | 11.661 | 10.660 |
| 總資產報酬率 ROA (%) | -0.984 | 2.865 | 4.847 | 5.577 | 5.397 |
| 投入資產回報率 ROIC (%) | -1.298 | 3.696 | 6.416 | 7.461 | 7.323 | 邊際利潤分析 |
| 銷售毛利率 (%) | 34.490 | 49.374 | 48.137 | 53.348 | 54.631 |
| 營業利潤率 (%) | 2.855 | 6.064 | 8.039 | 9.567 | 9.493 |
| 息稅前利潤/營業總收入 (%) | 1.105 | 7.123 | 9.223 | 10.718 | 10.800 |
| 淨利潤/營業總收入 (%) | -1.331 | 4.926 | 6.961 | 8.513 | 8.500 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | -3,607.629 | 84.496 | 90.236 | 100.867 | 97.452 |
| 價值變動淨收益/利潤總額(%) | 198.884 | -8.117 | -0.241 | -1.514 | -0.941 |
| 營業外收支淨額/利潤總額(%) | 4,071.257 | -0.453 | 0.149 | 1.061 | 2.087 | 償債能力分析 |
| 流動比率 (X) | 1.139 | 1.103 | 1.086 | 1.100 | 1.182 |
| 速動比率 (X) | 0.791 | 0.775 | 0.833 | 0.876 | 0.983 |
| 資產負債率 (%) | 57.723 | 47.765 | 46.867 | 47.928 | 45.604 |
| 帶息債務/全部投入資本 (%) | 54.347 | 40.407 | 37.123 | 37.351 | 33.651 |
| 股東權益/帶息債務 (%) | 81.230 | 145.145 | 167.777 | 166.714 | 196.041 |
| 股東權益/負債合計 (%) | 56.284 | 96.766 | 101.180 | 97.342 | 107.845 |
| 利息保障倍數 (X) | 0.939 | 6.560 | 7.871 | 10.224 | 9.772 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 83.327 | 85.521 | 80.908 | 80.477 | 83.813 |
| 存貨周轉天數 (天) | 106.150 | 124.213 | 94.959 | 95.116 | 95.837 |
| 備註： | 即時報價更新時間為 18/12/2025 12:12 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
